Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...
The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...
Hosted on MSN1mon
Purdue Pharma and the Sackler family to pay $7.4 billion in settlement over the toll of OxyContinMembers of the family who own OxyContin maker Purdue Pharma ... With Sweeping Claims of Presidential Power How to Prune a Fig Tree for an Abundant Harvest, According to Horticulturists My wife ...
A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...
Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...
The Sackler family and Purdue Pharma have agreed to a combined $7.4 billion settlement, according to the Utah Department of Commerce. Utah’s share would be $57 million of it if the state agrees ...
Purdue Pharma and the Sackler family will pay $7.4 billion for their role in the opioid epidemic. Delaware will receive over $27 million from the settlement. The settlement comes just shy of a ...
Purdue Pharma and its principal owners the Sackler family have agreed to pay a $7.4 billion settlement to end federal court claims made by 15 states due to the opioid crisis fueled by OxyContin ...
If one is not reached, it could open the floodgates to lawsuits against Sackler family members.The new settlement could bring to a close a chapter in a long legal saga over the toll of an opioid ...
Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...
The deal comes after the US Supreme Court last year rejected a $6 billion pact that would have protected Purdue’s owners, members of the billionaire Sackler family, from any further litigation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results